维普中文期刊产品整合服务
65篇 您的检索式:作者名="TANNIR"
    题名 作者 年代 出处 被引量
1Association between sarcopenic obesity and higher risk of type 2 diabetes in adults: A systematic review and meta-analysis显示文摘BACKGROUND The coexistence of sarcopenia and obesity is referred to as sarcopenic obesity(SO)and it has been hypothesized that the two components of SO may synergistically increase their negative effects. However, many uncertainties still surround this condition especially with regard to its potential negative effects on health outcomes.AIM To conduct a systematic review to determine the prevalence of sarcopenia among adults with overweight and obesity and to investigate whether SO was associated with a higher risk of type 2 diabetes(T2 D).METHODS This study was conducted in adherence with the Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines. Literature searches, study selection, methodology development and quality appraisal were performed independently by two authors and the data were collated by means of metaanalysis and narrative synthesis.RESULTS Of the 606 articles retrieved, 11 studies that comprised a total of 60118 adults with overweight and obesity of both genders met the inclusion criteria and were reviewed, revealing two main findings. First, the overall prevalence of sarcopenia is 43% in females and 42% in males who are with overweight and obesity.Secondly, the presence of SO increases the risk of T2D by 38% with respect to those without SO(OR = 1.38, 95%CI: 1.27-1.50).CONCLUSION A high prevalence of sarcopenia has been found among adults with overweight and obesity regardless of their gender and this condition seems to be associatedwith a higher risk of T2D. Clinician should be aware of this scenario in their clinical practice for the better management of both obesity and T2D.Dima Khadra Leila Itani Hana Tannir Dima Kreidieh Dana El Masri Marwan El Ghoch 2019World Journal of Diabetes2019,10,5:6
2Collision tumor of the kidney composed of clear cell carcinoma and collecting duct carcinoma: report of a case with unusual morphology and clinical follow-up显示文摘We report the case of a 67-year-old female who presented with a large renal mass. Gross examination of the nephrectomy specimen demonstrated a 6-cm renal mass that invaded into the renal sinus and perinephric fat. Histologic examination revealed two distinct tumor types. The first type was a conventional(clear cell) renal cell carcinoma that was of low nuclear grade and comprised the minority of the overall tumor. The second type was a high-grade collecting duct carcinoma with glandular/tubular differentiation and composed the majority of the tumor. Immunohistochemical studies demonstrated distinctive patterns of the two tumor types, thus confirming two distinct lineages. Five months postoperatively, the patient developed metastasis to the lungs and right hilar lymph node region. A fine needle aspiration of a lung nodule demonstrated a metastatic, poorly differentiated carcinoma, similar to the collecting duct carcinoma component in the kidney. Collision tumors of the kidney are rare with fewer than 10 cases reported in the literature. Our report further expands the spectrum of this rare phenomenon.Rhonda Burch-Smith Nizar M Tannir Erika Resetkova Pheroze Tamboli Priya Rao 2014Chinese Journal of Cancer2014,33,7:3
3Gene and protein expression markers of response tocombined antiangiogenic and epidermal growth factortargeted therapy in renal cell carcinoma显示文摘TsavachidouFenner D Tannir N Tamboli P 2010Ann On-coU2010,21,8:1
4Heart failure associated with sunitinib rnalate a multitargeted receptor tyrosine kinase inhibitor 显示文摘Khakoo Ay Kassiatis CM Tannir N 2008Cancer2008,112,11:1
5Correlation of survival with tumor histology, age, and prognostic risk group for previously untreated patients with advanced renal cell carcinoma ( adv RCC) receiving temsirolimus (TEMSR) or interferon-alpha (IFN)显示文摘DUTCHER JP SZCZYLIK C TANNIR N 2007J Clin Oncol2007,25,:1
6A Phase II Trial of Gemcitabine Plus Capecitabine for Metastatic Renal Cell Cancer Previously Treated With Immunotherapy and Targeted Agents显示文摘Nizar M. Tannir Peter F. Thall Chaan S. Ng Xuemei Wang Leiko Wooten Arlene Siefker-Radtke Paul Mathew Lance Pagliaro Christopher Wood Eric Jonasch 2007The Journal of Urology2007,,:1
7Primary tumor response to targeted agents in patients with metastatic renal cell carcinoma 显示文摘Abel EJ Culp SH Tannir NM 2011European urology2011,59,1:1
8Role of partial nephrectomyas cytoreduction in the management of metastatic renal cell carcinoma显示文摘Karam JA Babaian KN Tannir NM 2015Minerva Urol Nefrol2015,67,2:1
9Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma 显示文摘Karam JA BaLalan KN Tannir NM 2015Minerva Urol Nefrol2015,67,:1
10Age-related evolution of amyloid burden,iron load,and MR relaxation times in a transgenic mouse model of Alzheimer's disease显示文摘El Tannir El Tayara N Delatour B Le Cudennec C 2006Neurobiol Dis2006,22,:1
11Repetitive paravertebral nerve block using a catheter technique for pain relief in postherpetic neuralgia显示文摘Najal ZM Maaliki H Tannir MA 2006BJ A2006,96,3:1
12Occipital nerve blockade for cervicogenie headache: a double blind randomized controlled clinical trial显示文摘Naja ZM El-Rajab M AI Tannir MA el al 2006Pain Pract2006,6,2:1
13Patterns of disease pro- gression in metastatic renal cell carcinoma patients treated with antivascular agents and interferon 显示文摘Plimack E R Tannir N Lin E 2009Cancer2009,115,9:1
14Landscape of DNA virus associations across human malignant cancers:analysis of 3775cases using RNA-Seq显示文摘Khoury J D Tannir N M Williams M D 2013J Virol2013,87,16:1
15Targeted therapy for locally advanced renal cell carcinoma显示文摘Jonasch E Tannir NM 2010Target Oncol2010,5,:1
16Surgical morbidity associated with administration of targeted molecular therapies before cytoreductive nephrectomy or resection of locally recurrent renal cell carcinoma显示文摘Margulis V Matin SF Tannir N 2008Journal of Urology2008,,01:1
17Early primary tumor size reduction is an independent predictor of improved o- verall survival in metastatic renal cell carcinoma patients treated with sunitinib显示文摘ABEL EJ CULP SH TANNIR NM 2011Eur Urol2011,60,6:1
18Characterization of in vivo MRI detectable thalamic amyloid plaques from APP/PS1 mice 显示文摘Dhenain M Tannir E Tayara N 2009Neurobiol Aging2009,30,:1
19Randomized trial of ad- juvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma 显示文摘Margulis V Matin SF Tannir N 2009Urology2009,73,2:1
20A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancer显示文摘Small E J Fontana J Tannir N 2007BJU Int2007,100,4:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费